Jen Nwankwo, PhD.
Healthcare Strategist and Investor Bain & Company, Boston, MA
“Target Validation of Calpain-1 as a Novel Regulator of Platelet Hyperactivity and Pain Sensitivity in a Humanized Mouse Model of Severe Sickle Cell Disease”
Virginia Commonwealth University, School of Medicine
“Structural and Biochemical Studies of HSP 70 Molecular Chaperones”
Wayne State University, Division of Chemistry
"Chemical Approaches for Characterizing Protein Glutathionylation"
Virginia Commonwealth University, Pharmacotherapy and Outcomes Science
“Genes and Epigenetic Mechanisms Mediating Central Nervous System Drug Response”
Virginia Commonwealth University, Department of Biology
“Statins Inhibit Mast Cell-Mediated Inflammation”
National Cancer Institute, Maryland, Division of Cancer Prevention
“Research Funding by the National Cancer Institute: An Insiders Perspective”
John Hopkins Medicine, Maryland, Dept. of Pharmacology and Molecular Sciences
"Targeting a Bacterial Metabolic Branch Point through Inhibition of DXP Synthase"
Virginia Commonwealth University, Department of Pharmaceutics
“Dendrimer Nanocarries for Transport Modulation Across the Pulmonary Epithelium”